PAMI
LEGN icon

Perseverance Asset Management International’s Legend Biotech LEGN Stock Holding History

Perseverance Asset Management International’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,743
Closed -$391K – 14
2021
Q3 		$391K Sell
7,743
-7,745
-50% -$322K 0.18% 15
2021
Q2 		$635K Hold
15,488
– – 0.2% 17
2021
Q1 		$449K Buy
+15,488
New +$422K 0.11% 17

Other funds holding LEGN

HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Perseverance Asset Management International's LEGN Position: Q4 2021 in Review

Perseverance Asset Management International sold out of Legend Biotech (LEGN) in Q4 2021, closing a stake of 7,743 shares — an estimated $391K sold.

Perseverance Asset Management International first reported a position in LEGN in Q1 2021 and held it in 3 quarters. The position peaked at $635K in Q2 2021. 139 funds tracked by Wall St. Rank hold LEGN as of Q4 2021.

  • Perseverance Asset Management International reported no remaining Legend Biotech position as of Q4 2021 after selling out during the quarter.
  • Perseverance Asset Management International sold 7,743 Legend Biotech shares in Q4 2021, an estimated $391K.
  • Perseverance Asset Management International first reported a position in Legend Biotech in Q1 2021 and held it in 3 quarters.
  • Perseverance Asset Management International's Legend Biotech position peaked at $635K in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2021.

Based on Perseverance Asset Management International's 13F filing for Q4 2021, filed 14 Feb 2022.